Results 91 to 100 of about 16,115 (202)

Hyperprolactinemia diagnostics – dilemmas over optimal selection of prolactinemia time points [PDF]

, 2015
Introduction Laboratory discrimination of pathologic hyperprolactinemia is an important step in the diagnosis of pathology influencing overall health and fertility.
Konrad Szosland, Konrad Szosland, Lewinski, A., Magdalena Stasiak, Andrzej Lewiński, Andrzej Lewiński, Stasiak, M., Szosland, K., Magdalena Stasiak   +8 more
core   +2 more sources

Hyperprolactinemia in a Patient with Sheehan's Syndrome - Case Report

Endocrinology Research and Practice, 2010
Lactation failure is the first and the commonest manifestation of Sheehan's syndrome. We report the long-term follow-up of a patient with Sheehan's syndrome who presented with hyperprolactinemia rather than prolactin deficiency.
Bashir A Laway, Mohd Asharf Ganie
doaj   +2 more sources

BONE MINERAL DENSITY AND BONE TURNOVER IN PREMENOPAUSAL WOMEN WITH MILD HYPERPROLACTINEMIA

, 2012
Context. Bone mineral density (BMD) loss and progressive bone loss have been detected in patients with untreated hyperprolactinemia.
Ozturk, G. F., Kadioglu, A., Kadioglu, P., Celik, O., Kadioglu A., A, Cclik O., O, Oztürk G.f., Gf   +6 more
core   +1 more source

Hyperprolactinemia [PDF]

PONS - medicinski casopis, 2017
Aleksandar Aleksic, Vojkan Stanojevic, Saska Manic, Mile Despotovic, Natasa Savic, Cedomirka Stanojevic, Milena Despotovic   +6 more
  +4 more sources

MODERN APPROACH ТО DIAGNOSTCS AND TREATMENT OF PATHOLOGICAL HYPERPROLACTINEMIA

Acta Biomedica Scientifica, 2012
Hyperprolactinemia is one of the most frequent neuroendocrinal disorders and consequently questions of diagnostics and treatment of this syndrome continue to remain actual.
I. A. Ilovayskaya
doaj  

Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach

, 2018
While prolactin is most well known for its role in lactation and suppression of reproduction, its physiological functions are quite diverse. There are many etiologies of hyperprolactinemia, including physiologic as well as pathologic causes.
Samara Levine, Ozgul Muneyyirci-Delale
core   +1 more source

A real-world analysis of healthcare costs and relative risk of hyperprolactinemia associated with antipsychotic treatments in the United States

, 2018
Aims: Antipsychotic medications are associated with an increased risk of hyperprolactinemia, but differ in their propensity to cause this complication.
Maëlys Touya (5701326), Mallik Greene (5701324), Martin Cloutier (5100926), Annie Guerin (2946111), Patrick Gagnon-Sanschagrin (4740738)   +4 more
core   +1 more source

Hyperprolactinemia [PDF]

The Journal of Clinical Endocrinology & Metabolism, 2010
Michael H. Bloch, Michael H. Bloch, Mark A. Geyer, David C. S. Roberts, Eileen M. Joyce, Jonathan P. Roiser, John H. Halpern, Joji Suzuki, Pedro E. Huertas, Torsten Passie, John H. Halpern, Joji Suzuki, Pedro E. Huertas, Torsten Passie, Joji Suzuki, Torsten Passie, Pedro E. Huertas, John H. Halpern, Joji Suzuki, Torsten Passie, Pedro E. Huertas, John H. Halpern, David E. Nichols, Marie-Louise G. Wadenberg, Trevor W. Robbins, David S. Baldwin, Sophie Tambour, John C. Crabbe, Lucio Tremolizzo, Gessica Sala, Carlo Ferrarese, Brian L. Odlaug, Jon E. Grant, Paul D. Callaghan, Iain S. McGregor, Murray R. Thompson, Sarah Morgan, Angus Mackay, E. Ernst, Lawrence H. Price, Michael M. Morgan, MacDonald J. Christie, Susan Jones, Andrew Young, Elizabeth C. Warburton, Stephen J. Hill, Anthony R. Isles, Lawrence S. Wilkinson, Subhash C. Pandey, Subhash C. Pandey, Subhash C. Pandey, Aldo Badiani, James Winslow, Susan Jones, Jill B. Becker, Lucio Tremolizzo, Gessica Sala, Carlo Ferrarese, Paul D. Callaghan, Iain S. McGregor, Murray R. Thompson, David E. Nichols, Jason C. G. Halford, Stephen B. Dunnett, Martine Cador, Naheed (Max) Mirza, Andrea Bari, Yesne Alici, William Breitbart, Andrea Bari, Becky Kinkead, Charles B. Nemeroff, Lucy C. Guillory, Jason C. G. Halford, Ennio Esposito, William Invernizzi, Gary Remington, Tomasz Schneider, Michel Billiard, Michel Billiard, Alyson J. Bond, Paolo Nencini, Michele S. Milella, Brian E. Leonard, Yesne Alici, William Breitbart, Luis de Lecea, Michel Billiard, Samuel B. Hutton, Jason C. G. Halford, R. H. De Rijk, E. R. de Kloet, Tooru M. Mizuno, Maria Isabel Colado, A. Richard Green   +94 more
openaire   +2 more sources

Pathological hyperprolactinemia and the control of reproductive function in women

, 1981
Amenore, galaktore ve infertilite olgularında sık olarak rastlanan hiperprolaktinemi, bu konu üzerindeki araştırmaların yoğunlaşmasına sebep olmuştur. Kadınlarda 3 tip hiperprolaktinemi vardır. Patolojik hiperprolaktinemi, farmakolojik hiperprolaktinemi,

core  

Using Polyethylene Glycol Precipitation to Differentiate between Macroprolactinemia and Hyperprolactinemia

Siriraj Medical Journal, 2014
Hyperprolactinemia is a common endocrine disorder which clinically manifestats in reproductive period and presents with hypogonadism, galactorrhea and symptoms related to tumor mass effects.
Chongdee Dangrat
doaj